Related Experiment Video
Updated: Apr 26, 2026
08:22
Orthotopic Left Lung Transplantation in Rats
Published on: July 3, 2025
881
Lung transplantation for interstitial lung diseases
1Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
Current Opinion in Pulmonary Medicine
|July 25, 2014
Summary
Lung transplantation is a vital treatment for end-stage interstitial lung diseases, offering survival benefits. However, donor organ shortages and long-term survival challenges persist for lung transplant recipients.
Area of Science:
- Pulmonology
- Transplant Surgery
Background:
- Lung transplantation is an established therapy for end-stage lung diseases.
- Approximately 3600 lung transplantations are performed globally each year.
- Donor organ scarcity results in a significant number of patients dying before receiving a transplant.
Purpose of the Study:
- To provide an overview of the role of lung transplantation in interstitial lung diseases.
- To highlight the current status and challenges of lung transplantation for these conditions.
Main Methods:
- Review of current literature and registry data on lung transplantation for interstitial lung diseases.
- Analysis of procedural frequency, indications, and outcomes.
- Discussion of challenges including organ availability and long-term survival.
Main Results:
- Idiopathic pulmonary fibrosis accounts for 23% of lung transplant recipients.
- Emphysema, pulmonary fibrosis, and cystic fibrosis are the most common indications.
- Lung transplantation is limited by donor organ supply, and long-term survival rates are lower than other solid organ transplants.
Conclusions:
- Lung transplantation provides a survival advantage for carefully selected patients with interstitial lung diseases.
- Careful selection of candidates based on disease-specific factors and exclusion of contraindications is crucial.
